Cargando…

4138 Development of an Antibiofilm Resorbable Membrane for Treating Peri-implantitis

OBJECTIVES/GOALS: Peri-implantitis is the inflammation of peri-implant mucosa and subsequent loss of supporting bone. Its treatment is only <40% successful mainly due to persistent bacterial infection. The goal of this project is to increase success rates by developing a robust antibiofilm multi-...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Zhou, Rahimi, Joseph R., Fischer, Nicholas G., Chew, Hooi Pin, Aparicio, Conrado
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8823065/
http://dx.doi.org/10.1017/cts.2020.364
_version_ 1784646732524552192
author Ye, Zhou
Rahimi, Joseph R.
Fischer, Nicholas G.
Chew, Hooi Pin
Aparicio, Conrado
author_facet Ye, Zhou
Rahimi, Joseph R.
Fischer, Nicholas G.
Chew, Hooi Pin
Aparicio, Conrado
author_sort Ye, Zhou
collection PubMed
description OBJECTIVES/GOALS: Peri-implantitis is the inflammation of peri-implant mucosa and subsequent loss of supporting bone. Its treatment is only <40% successful mainly due to persistent bacterial infection. The goal of this project is to increase success rates by developing a robust antibiofilm multi-biomolecular membrane that can be placed around implant surfaces. METHODS/STUDY POPULATION: A collagen membrane was soaked in the antimicrobial peptide GL13K solution overnight to form an interpenetrating fibrillary network. The nanostructure of the membrane was imaged with scanning electron microscope (SEM). The hydrophobicity of the membrane was analyzed by water contact angle (WCA) measurements. The biodegradability was tested in a 0.01 mg/mL Type I collagenase solution for up to 5 weeks. The antimicrobial activity of the membrane was assessed with Gram-positive oral bacteria Streptococcus gordonii. The cytotoxicity was evaluated by culturing human gingival fibroblasts (HGF), and the osteogenesis was assessed using preosteoblasts MC3T3. Pure collagen membrane was used as the control. Statistical significance (p<0.05) was determined by one-way ANOVA with Tukey’s HSD test. RESULTS/ANTICIPATED RESULTS: The antimicrobial peptide GL13K self-assembled to short fibrils (< 1 µm long), which entangled with the larger collagen fibers (around 200 nm in diameter). The collagen fibers presented characteristic periodic banding structures, which provided biomimetic cues for cell behavior as extracellular matrix. The interpenetrated GL13K fibrils turned the highly hydrophilic collagen membrane to a hydrophobic membrane (WCA = 135 °) and significantly reduced the rate of degradation by collagenases. The developed membrane was efficient in preventing the attachment of S. gordonii. A large portion of the attached bacteria was killed on the surface of the membrane. The incorporation of GL13K did not affect the cytocompatibility of the membrane for HGF. DISCUSSION/SIGNIFICANCE OF IMPACT: We developed an antibiofilm membrane with interpenetrating collagen and antimicrobial peptide fibrils. The strong antimicrobial activity and low cytotoxicity support its further translational evaluation as scaffolds for increasing success rate in treating peri-implantitis.
format Online
Article
Text
id pubmed-8823065
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-88230652022-02-18 4138 Development of an Antibiofilm Resorbable Membrane for Treating Peri-implantitis Ye, Zhou Rahimi, Joseph R. Fischer, Nicholas G. Chew, Hooi Pin Aparicio, Conrado J Clin Transl Sci Translational Science, Policy, & Health Outcomes Science OBJECTIVES/GOALS: Peri-implantitis is the inflammation of peri-implant mucosa and subsequent loss of supporting bone. Its treatment is only <40% successful mainly due to persistent bacterial infection. The goal of this project is to increase success rates by developing a robust antibiofilm multi-biomolecular membrane that can be placed around implant surfaces. METHODS/STUDY POPULATION: A collagen membrane was soaked in the antimicrobial peptide GL13K solution overnight to form an interpenetrating fibrillary network. The nanostructure of the membrane was imaged with scanning electron microscope (SEM). The hydrophobicity of the membrane was analyzed by water contact angle (WCA) measurements. The biodegradability was tested in a 0.01 mg/mL Type I collagenase solution for up to 5 weeks. The antimicrobial activity of the membrane was assessed with Gram-positive oral bacteria Streptococcus gordonii. The cytotoxicity was evaluated by culturing human gingival fibroblasts (HGF), and the osteogenesis was assessed using preosteoblasts MC3T3. Pure collagen membrane was used as the control. Statistical significance (p<0.05) was determined by one-way ANOVA with Tukey’s HSD test. RESULTS/ANTICIPATED RESULTS: The antimicrobial peptide GL13K self-assembled to short fibrils (< 1 µm long), which entangled with the larger collagen fibers (around 200 nm in diameter). The collagen fibers presented characteristic periodic banding structures, which provided biomimetic cues for cell behavior as extracellular matrix. The interpenetrated GL13K fibrils turned the highly hydrophilic collagen membrane to a hydrophobic membrane (WCA = 135 °) and significantly reduced the rate of degradation by collagenases. The developed membrane was efficient in preventing the attachment of S. gordonii. A large portion of the attached bacteria was killed on the surface of the membrane. The incorporation of GL13K did not affect the cytocompatibility of the membrane for HGF. DISCUSSION/SIGNIFICANCE OF IMPACT: We developed an antibiofilm membrane with interpenetrating collagen and antimicrobial peptide fibrils. The strong antimicrobial activity and low cytotoxicity support its further translational evaluation as scaffolds for increasing success rate in treating peri-implantitis. Cambridge University Press 2020-07-29 /pmc/articles/PMC8823065/ http://dx.doi.org/10.1017/cts.2020.364 Text en © The Association for Clinical and Translational Science 2020 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Translational Science, Policy, & Health Outcomes Science
Ye, Zhou
Rahimi, Joseph R.
Fischer, Nicholas G.
Chew, Hooi Pin
Aparicio, Conrado
4138 Development of an Antibiofilm Resorbable Membrane for Treating Peri-implantitis
title 4138 Development of an Antibiofilm Resorbable Membrane for Treating Peri-implantitis
title_full 4138 Development of an Antibiofilm Resorbable Membrane for Treating Peri-implantitis
title_fullStr 4138 Development of an Antibiofilm Resorbable Membrane for Treating Peri-implantitis
title_full_unstemmed 4138 Development of an Antibiofilm Resorbable Membrane for Treating Peri-implantitis
title_short 4138 Development of an Antibiofilm Resorbable Membrane for Treating Peri-implantitis
title_sort 4138 development of an antibiofilm resorbable membrane for treating peri-implantitis
topic Translational Science, Policy, & Health Outcomes Science
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8823065/
http://dx.doi.org/10.1017/cts.2020.364
work_keys_str_mv AT yezhou 4138developmentofanantibiofilmresorbablemembranefortreatingperiimplantitis
AT rahimijosephr 4138developmentofanantibiofilmresorbablemembranefortreatingperiimplantitis
AT fischernicholasg 4138developmentofanantibiofilmresorbablemembranefortreatingperiimplantitis
AT chewhooipin 4138developmentofanantibiofilmresorbablemembranefortreatingperiimplantitis
AT aparicioconrado 4138developmentofanantibiofilmresorbablemembranefortreatingperiimplantitis